| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $18.1M | +26.1% |
| SG&A Expense | $17.3M | +3.2% |
| Operating Income | -$62.1M | -47.6% |
| Pre-tax Income | -$63.1M | -51.9% |
| Net Income | -$63.1M | -51.9% |
| EPS (Basic) | -$0.75 | -11.9% |
| EPS (Diluted) | -$0.75 | -11.9% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $73.0M | +188.6% |
| Short-term Investments | $32.9M | -25.8% |
| Inventory | $648K | — |
| Current Assets | $111.9M | +51.4% |
| Total Assets | $113.6M | +50.4% |
| Current Liabilities | $14.0M | +72.0% |
| Long-term Debt | $57.2M | +7.2% |
| Total Liabilities |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$49.0M | -70.0% |
| Capital Expenditures | $302K | +815.2% |
| Investing Cash Flow | $11.2M | +35.8% |
| Financing Cash Flow | $85.5M | +166.3% |
| Free Cash Flow | -$49.3M | -70.8% |
| $71.8M |
| +15.1% |
| Stockholders' Equity | $41.8M | +217.7% |